Pharma Cloudview ApS
CVRCVR number38887513Opløst
Company financials
Key figures
Updated 17 Dec 2020
- Return on assets
- -613.4%
- Return on equity
- –
- Current ratio
- 9.6%
- Equity ratio
- -942%
Profit and loss
| Reporting period | |
|---|---|
Gross profit | -9,798 |
Operating profit | -129,798 |
Finance expenses | 477 |
Tax expense | 0 |
Profit/loss for the year | -130,275 |
Employees
| Reporting period | |
|---|---|
Avg. employees | 1 |
Balance sheet
| Reporting period | |
|---|---|
Cash and cash equivalents | 21,159 |
Current assets | 21,159 |
Non-current assets | 0 |
Total assets | 21,159 |
Equity | -199,315 |
Liabilities | 220,474 |
Current liabilities | 220,474 |
Working capital
| Reporting period | |
|---|---|
Other current receivables | 0 |
Trade payables | 7,318 |
Other current payables | 0 |
Capital and dividend
| Reporting period | |
|---|---|
Contributed capital | 50,000 |
Retained earnings | -249,315 |
Annual report highlights
Official annual report · 2020Open official report
Business and development
Primary activities
Selskabets formål er at udvikle og sælge compliance understøttende systemer til indledningsvist Pharma industrien. Ideelt på sigt ligeledes til andre industrier.
Risks and material matters
Significant events after the reporting period
Selskabets ledelse forventer at afvikle selskabet i løbet af regnskabsåret 2020/21.
Commitments and security
Contingent liabilities
Selskabet er sambeskattet med H.Billeschou Holding ApS (Administrationsselskab) og hæfter solidarisk med øvrige sambeskattede selskaber for betaling af selskabsskat samt for kildeskat på udbytter, renter og royalties.
Create a free account to see up to 9 years of financial history
Create free account